Challenges in Delivery of Therapeutic Genomics and Proteomics
portes grátis
Challenges in Delivery of Therapeutic Genomics and Proteomics
Shahiwala, Aliasgar; Surti, Naazneen
Elsevier Science Publishing Co Inc
03/2025
610
Mole
9780443274169
Pré-lançamento - envio 15 a 20 dias após a sua edição
Descrição não disponível.
1. Barriers to Gene and Protein Delivery
2. Gene Delivery Using Physical Methods
3. Gene Delivery Using Chemical Methods
4. Gene Delivery Using Viral Vectors
5. RNA based therapeutics
6. Protein and Peptide Delivery through Respiratory Pathway
7. Oral Delivery of Proteins and Peptides: Concepts and Applications
8. Parenteral Delivery of Peptides and Proteins
9. Other Routes of Protein and Peptide Delivery: Transdermal, Topical, Uterine, and Rectal
10. Computational tools in genomics and proteomics
11. CRISPR/Cas9 gene-editing for treating gene and protein disorders
12. Regulatory guidance on therapeutic proteomics and genomics
2. Gene Delivery Using Physical Methods
3. Gene Delivery Using Chemical Methods
4. Gene Delivery Using Viral Vectors
5. RNA based therapeutics
6. Protein and Peptide Delivery through Respiratory Pathway
7. Oral Delivery of Proteins and Peptides: Concepts and Applications
8. Parenteral Delivery of Peptides and Proteins
9. Other Routes of Protein and Peptide Delivery: Transdermal, Topical, Uterine, and Rectal
10. Computational tools in genomics and proteomics
11. CRISPR/Cas9 gene-editing for treating gene and protein disorders
12. Regulatory guidance on therapeutic proteomics and genomics
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Antibody induction; Antimicrobial peptides; Antisense oligonucleotides (ASOs); Barriers to protein absorption; Bioadhesive materials; Blood-brain barrier; Cell-penetrating peptides; Chemical vectors; Clinical requirements; CMC requirements; Computational tools; CRISPR/Cas9; Cyclodextrin; Data integration; DNA; Drug delivery technology; Drug therapy; Extracellular barriers; Fast-track approval; Functional annotation; Gene delivery; Gene editing; Gene gun; Gene therapy; Genetic disorders; Genome; Genomics; ICH guidelines; Immunogenicity; In vivo technique; Intracellular barriers; Lipids; Localized and systemic protein; Magnetoreception; Micro RNA; Microinjection; mRNA vaccines; Nanoinclusion technology; Nanoparticles; Noninvasive therapies; Nonviral vectors; Penetration enhancers; Peptide delivery; Peptides; Pharmaceutical regulations; Photoporation; Physical methods; Polymers; Preclinical and clinical studies; Protein delivery; Proteins; Proteins and peptides; Proteolytic enzyme; Proteomics; Rectal; Respiratory system; Ribozymes; RNA; RNA aptamers; RNA decoys; RNA interference (RNAi); Safety; Scale-up barriers; Sequence alignment; Small interfering RNA; Sonoporation; Stability studies; Surface modification; Targeted delivery; Therapeutic proteins; Topical; Transdermal; Transfection efficiency; Transferrin-based recombinant fusion protein technology; Uterine; Viral vectors
1. Barriers to Gene and Protein Delivery
2. Gene Delivery Using Physical Methods
3. Gene Delivery Using Chemical Methods
4. Gene Delivery Using Viral Vectors
5. RNA based therapeutics
6. Protein and Peptide Delivery through Respiratory Pathway
7. Oral Delivery of Proteins and Peptides: Concepts and Applications
8. Parenteral Delivery of Peptides and Proteins
9. Other Routes of Protein and Peptide Delivery: Transdermal, Topical, Uterine, and Rectal
10. Computational tools in genomics and proteomics
11. CRISPR/Cas9 gene-editing for treating gene and protein disorders
12. Regulatory guidance on therapeutic proteomics and genomics
2. Gene Delivery Using Physical Methods
3. Gene Delivery Using Chemical Methods
4. Gene Delivery Using Viral Vectors
5. RNA based therapeutics
6. Protein and Peptide Delivery through Respiratory Pathway
7. Oral Delivery of Proteins and Peptides: Concepts and Applications
8. Parenteral Delivery of Peptides and Proteins
9. Other Routes of Protein and Peptide Delivery: Transdermal, Topical, Uterine, and Rectal
10. Computational tools in genomics and proteomics
11. CRISPR/Cas9 gene-editing for treating gene and protein disorders
12. Regulatory guidance on therapeutic proteomics and genomics
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Antibody induction; Antimicrobial peptides; Antisense oligonucleotides (ASOs); Barriers to protein absorption; Bioadhesive materials; Blood-brain barrier; Cell-penetrating peptides; Chemical vectors; Clinical requirements; CMC requirements; Computational tools; CRISPR/Cas9; Cyclodextrin; Data integration; DNA; Drug delivery technology; Drug therapy; Extracellular barriers; Fast-track approval; Functional annotation; Gene delivery; Gene editing; Gene gun; Gene therapy; Genetic disorders; Genome; Genomics; ICH guidelines; Immunogenicity; In vivo technique; Intracellular barriers; Lipids; Localized and systemic protein; Magnetoreception; Micro RNA; Microinjection; mRNA vaccines; Nanoinclusion technology; Nanoparticles; Noninvasive therapies; Nonviral vectors; Penetration enhancers; Peptide delivery; Peptides; Pharmaceutical regulations; Photoporation; Physical methods; Polymers; Preclinical and clinical studies; Protein delivery; Proteins; Proteins and peptides; Proteolytic enzyme; Proteomics; Rectal; Respiratory system; Ribozymes; RNA; RNA aptamers; RNA decoys; RNA interference (RNAi); Safety; Scale-up barriers; Sequence alignment; Small interfering RNA; Sonoporation; Stability studies; Surface modification; Targeted delivery; Therapeutic proteins; Topical; Transdermal; Transfection efficiency; Transferrin-based recombinant fusion protein technology; Uterine; Viral vectors
